Gamma Biologicals Reports Earnings For Second Quarter and Six Months Ended September 30, 1997; Gamma-ReACT, Now FDA Approved to Market, Generates Interest at AABB.
Business Wire (November 13, 1997)
Permanent Link:
http://vlex.com/vid/gamma-biologicals-react-aabb-53749671
Id. vLex: VLEX-53749671
Acceda a este documento
y pruebe vLex GRATIS durante 3 días
Gamma Biologicals Reports Earnings For Second Quarter and Six Months Ended September 30, 1997; Gamma-ReACT, Now FDA Approved to Market, Generates Interest at AABB.
HOUSTON--(BUSINESS WIRE)--Nov. 13, 1997-- Gamma Biologicals, Inc. (Amex: GBL) today reported earnings for the second quarter and six months ended September 30, 1997. The company earned net income for the quarter of $321,000 (seven cents per share) on net sales of $4...
Try vLex for FREE for 3 days
Access legal information from United States including:
- Constitutions
- Forms and Contracts
- Legal Books and Journals
- Case Law
- News and Business
- Regulations
- U.S. Code
Try vLex without any commitment for 3 days and see why you need it.
3
days of Free Access
If you are already a vLex customer, Access Here
